68
Shanghai Haohai Biological Technology Co., Ltd.
6826.HK · HKSE
$16.32 -2.63% (-$0.44)
1M -1.55%
Market Cap ¥5.73B
P/E Ratio 39.44x
Div. Yield -
ROE 2.67%
Bulios Fair Price
$13.48
17.4% downside
Current Price
$16.32
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6826.HK is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
44 /100
Fair P/E 39.44x
EV/EBITDA 20.28x
P/S 2.46x
Growth
36 /100
Stable EPS growth 1.27%
Rev. growth 5.16%
Book val. growth 0.55%
Profitability
50 /100
Moderate Gross margin 65.20%
Net margin 6.24%
Op. margin 1.63%
Quality
11 /100
Poor ROIC 0.54%
ROE 2.67%
ROA 2.21%
Debt
85 /100
Low Debt/Equity 0.08x
Current ratio 3.49x
Int. coverage 2.10x
Stability
51 /100
Moderate Beta 0.47x
Rev. volatility 17.41%
EPS volatility 97.08%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6826.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Wu Jianying
Employees
1,999
Headquarters
Shanghai
Upcoming events
23 OCT
Earnings
Upcoming earnings report